CD34 Archives - Medical Conferences

RUBY: Promising data for first AsCas12a gene-editing therapy in sickle cell disease

Presented By

Dr Rabi Hanna, Cleveland Clinic, OH, USA

Trial

Phase 1/2, RUBY

Conference

EHA 2024

Type

Peer-reviewed article

12 August 2024 14:25

CD34+ stem cells promote reverse cardiac remodelling after acute MI

Presented By

Prof. Faiez Zannad, University of Lorraine, France

Trial

Phase 1/2, EXCELLENT

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:30

Gene editing in congenital neutropenia

Presented By

Dr Shuquan Rao, Harvard Medical School, USA

Conference

ASH 2019

Type

Peer-reviewed article

5 March 2020 15:43

site created by:

© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy

HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com